Magnetic selection of cytomegalovirus-specific CTL for use in antigen-specific donor leucocyte infusion.

被引：0
|
作者：
Keenan, R
Ainsworth, J
Assenmacher, M
Milligan, DW
Moss, PAH
机构：
[1] Univ Hosp, Birmingham, W Midlands, England
[2] Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England
[3] Miltenyi Biotec, Bergisch Gladbach, Germany
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1431
引用
收藏
页码：320A / 320A
页数：1
相关论文
共 50 条
  • [21] The induction of antigen-specific CTL by in situ Ad-REIC gene therapy
    Ariyoshi, Y.
    Watanabe, M.
    Eikawa, S.
    Yamazaki, C.
    Sadahira, T.
    Hirata, T.
    Araki, M.
    Ebara, S.
    Nasu, Y.
    Udono, H.
    Kumon, H.
    GENE THERAPY, 2016, 23 (05) : 408 - 414
  • [22] Antigen-specific CTL expanded with dendritic cells are skewed towards effector phenotype
    Chen, FE
    Duarte, R
    Barber, L
    Dodi, IA
    Travers, P
    Madrigal, A
    TISSUE ANTIGENS, 2002, 59 : 43 - 43
  • [23] Improvement of Antigen-Specific CTL Persistence By Transduction of Novel Artificial Adapter Molecule
    Miyao, Kotaro
    Terakura, Seitaro
    Watanabe, Keisuke
    Sakemura, Reona
    Julamanee, Jakrawadee
    Okuno, Shingo
    Kamoshita, Sonoko
    Takagi, Erina
    Koyama, Daisuke
    Goto, Tatsunori
    Hanajiri, Ryo
    Nishida, Tetsuya
    Murata, Makoto
    Kiyoi, Hitoshi
    BLOOD, 2016, 128 (22)
  • [24] Differential susceptibility of cells expressing allogeneic MHC or viral antigen to killing by antigen-specific CTL
    Lee, K
    Takenaka, H
    Yoneda, Y
    Goto, T
    Sano, K
    Nakanishi, M
    Eguchi, A
    Okada, M
    Tashiro, J
    Sakurai, K
    Kubota, T
    Yoshida, R
    MICROBIOLOGY AND IMMUNOLOGY, 2004, 48 (01) : 15 - 25
  • [25] Conversion from mixed to all donor chimerism following infusion of minor histocompatibility antigen-specific donor lymphocytes in dogs.
    Georges, G
    Storb, R
    Yu, C
    Torok-Storb, B
    Thompson, J
    Bruno, B
    Nash, R
    BLOOD, 1998, 92 (10) : 435A - 435A
  • [26] CYTOMEGALOVIRUS-SPECIFIC ANTIBODIES TO AN IMMEDIATE EARLY ANTIGEN AND A LATE MEMBRANE ANTIGEN AND THEIR POSSIBLE ROLE IN CONTROLLING SECONDARY CYTOMEGALOVIRUS-INFECTION
    VANZANTEN, J
    VANDERGIESSEN, M
    VANDERVOORT, LHM
    VANSON, WJ
    VANDERBIJ, W
    THE, TH
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 83 (01): : 102 - 107
  • [27] Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease
    Odendahl, Marcus
    Grigoleit, G. Ulrich
    Boenig, Halvard
    Neuenhahn, Michael
    Albrecht, Julia
    Anderl, Florian
    Germeroth, Lothar
    Schmitz, Marc
    Bornhaeuser, Martin
    Einsele, Hermann
    Seifried, Erhard
    Busch, Dirk H.
    Tonn, Torsten
    CYTOTHERAPY, 2014, 16 (09) : 1245 - 1256
  • [28] Induction of Donor Specific Tolerance in Recipients of HLA Disparate Living Donor Kidney Allografts by Donor Stem Cell Infusion.
    Leventhal, Joseph R.
    Miller, Joshua
    Gallon, Lorenzo
    Abecassis, Michael M.
    Ravindra, Kadiyala Y. A.
    Reed, Elizabeth
    Herzig, Roger
    Ildstad, Suzanne T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 114 - 114
  • [29] FOLLOWING THE FATE OF DONOR-SPECIFIC T-CELL RECEPTORS IN THE DEVELOPMENT OF DONOR ANTIGEN-SPECIFIC HYPOREACTIVITY
    JACKSON, A
    DONAHUE, P
    MCSHERRY, C
    SANTAMARIA, P
    BUTTERS, K
    REINSMOEN, NL
    HUMAN IMMUNOLOGY, 1993, 37 : 43 - 43
  • [30] Streptamer versus tetramer-based selection of functional cytomegalovirus-specific T cells
    Wang, Xin-Chao
    Pang, Hua
    Xu, Xun
    Schmitt, Anita
    Freund, Mathias
    Schmitt, Michael
    Chen, Bao-An
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2013, 112 (06) : 338 - 345
12345